tiprankstipranks
pc:laigo

Laigo Bio

An early stage biotech company based in the Netherlands, pioneering novel therapies using its proprietary SureTAC™ precision membrane protein degradation platform. The company focuses on selective degradation of membrane-bound targets involved in autoimmune and inflammatory diseases.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 04, 2025
Seed Round
$11.50M

Investors

Investor Name
Funding Round

Related News and Analysis